Evidence map›Paper›PMID 35705669›Full record

ArticleScientific reports2022

Enhanced HIV SOSIP Envelope yields in plants through transient co-expression of peptidyl-prolyl isomerase B and calreticulin chaperones and ER targeting.

Yvonne J Rosenberg, Xiaoming Jiang, Jonathan P Lees, Lori A Urban, Lingjun Mao, Markus Sack

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yvonne J RosenbergPlantVax Corporation, Rockville, MD, USA. yjr@plantvax.com.
Xiaoming JiangPlantVax Corporation, Rockville, MD, USA.
Jonathan P LeesPlantVax Corporation, Rockville, MD, USA.
Lori A UrbanPlantVax Corporation, Rockville, MD, USA.
Lingjun MaoPlantVax Corporation, Rockville, MD, USA.
Markus SackPro-SPR GmbH, Alsdorf, Germany.
IDEX Corporation (United States) · US

Funding

Increased Expression of an HIV CH505.664 SOSIP Envelope in Plants by Modulation of ER Chaperones75N93019C00010 · NIAID · PLANTVAX, INC. · PI ROSENBERG, YVONNE · 2019 to 2019
$288k
NIAID NIH HHS 75N93019C00010
6 · The paper itself

Abstract

High yield production of recombinant HIV SOSIP envelope (Env) trimers has proven elusive as numerous disulfide bonds, proteolytic cleavage and extensive glycosylation pose high demands on the host cell machinery and stress imposed by accumulation of misfolded proteins may ultimately lead to cellular toxicity. The present study utilized the Nicotiana benthamiana/p19 (N.b./p19) transient plant system to assess co-expression of two ER master regulators and 5 chaperones, crucial in the folding process, to enhance yields of three Env SOSIPs, single chain BG505 SOSIP.664 gp140, CH505TF.6R.SOSIP.664.v4.1 and CH848-10.17-DT9. Phenotypic changes in leaves induced by SOSIP expression were employed to rapidly identify chaperone-assisted improvement in health and expression. Up to 15-fold increases were obtained by co-infiltration of peptidylprolvl isomerase (PPI) and calreticulin (CRT) which were further enhanced by addition of the ER-retrieval KDEL tags to the SOSIP genes; levels depending on individual SOSIP type, day of harvest and chaperone gene dosage. Results are consistent with reducing SOSIP misfolding and cellular stress due to increased exposure to the plant host cell's calnexin/calreticulin network and accelerating the rate-limiting cis-trans isomerization of Xaa-Pro peptide bonds respectively. Plant transient co-expression facilitates rapid identification of host cell factors and will be translatable to other complex glycoproteins and mammalian expression systems.

Indexed as

HIV-1HIV InfectionsAnimalsAntibodies, NeutralizingCalreticulinenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesMammalsPeptidylprolyl IsomeraseProtein MultimerizationAntibodies, NeutralizingCalreticulinenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesPeptidylprolyl Isomerase

Identifiers

PMID35705669
PMCPMC9200074
OpenAlexW4282982150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.